Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation

Author： Parienti Jean-Jacques   Peytavin Gilles  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.4, 2011-04, pp. : 495-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic profile of once-daily cyclobenzaprine extended-release

By Darwish Mona   Hellriegel Edward T  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1425-1436

Informa Healthcare

Access to resources Recommend Favorite

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease

By Perez Lloret Santiago   Rascol Olivier  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2221-2230

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Ritalin ® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

By Biederman J.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 833-841

Adis International

Access to resources Recommend Favorite

Multiple Dose Pharmacokinetics of a New Once Daily Extended Release Tolterodine Formulation Versus Immediate Release Tolterodine

By Olsson B.  

Clinical Pharmacokinetics, Vol. 40, Iss. 3, 2001-01 ,pp. : 227-235

Adis International

Access to resources Recommend Favorite

Food Does Not Influence the Pharmacokinetics of a New Extended Release Formulation of Tolterodine for Once Daily Treatment of Patients with Overactive Bladder

By Olsson B.  

Clinical Pharmacokinetics, Vol. 40, Iss. 2, 2001-01 ,pp. : 135-143

Adis International

Access to resources Recommend Favorite